Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Kifissia

45 clinical trials in Kifissia, Greece across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kifissia at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

45 trials in Kifissia

Open in trial search

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:GreeceGreece
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Study of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Bioversys S.A.S.

Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.

A study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Saline

Bladder cancer

Recruiting

A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Back pain

Recruiting

Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac potassium
  • Sponsor:Verisfield Single Member S.A.

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Kifissia

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials focusing on non-small cell lung cancer and innovative treatment combinations. Studies evaluating novel therapies including immunotherapy agents and targeted treatments for various stages of cancer.

  • Advanced NSCLC Treatments
  • Breast Cancer Therapies
  • Gastrointestinal Cancer Studies

Multiple trials exploring combination therapies with chemotherapy and radiation for enhanced treatment outcomes.

02 Cardiovascular Studies

Important research in atrial fibrillation and stroke prevention, investigating new therapeutic approaches for cardiovascular conditions. Studies focusing on novel anticoagulants and heart attack treatments.

  • Stroke Prevention Therapies
  • Cardiac Rhythm Management
  • Acute Coronary Syndrome

Innovative treatments being evaluated to improve patient outcomes in emergency cardiovascular care.

03 Neurological Research

Clinical investigations targeting Alzheimer's disease and associated conditions, with a focus on managing psychosis and cognitive symptoms. Studies evaluating novel therapeutic approaches.

  • Alzheimer's Disease Treatments
  • Psychosis Management
  • Cognitive Function Studies

Dedicated research into improving quality of life for patients with neurodegenerative conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.